I am pleased to be engaged with healthcare policy making at the institutional, local, and national levels. In addition the service below, please see this page of professional society policy statements.
End of Life Advisory Boards
I serve on the advisory board for the Completed Life Initiative.
I serve on the advisory board for the American Clinicians Academy for Medical Aid in Dying
End-of-Life Testimony to Tribunals
Multiple letters to the Uniform Law Commission study committee on the Uniform Determination of Death Act (2021).
Written testimony on amendments to the Hawaii Our Care, Our Choice Act (2021).
Written testimony on amendments to the New York proxy law (2021).
I testified, by invitation, before the U.S. President's Council on Bioethics.
I testified, by invitation, before the Minnesota Senate.
I testified, by invitation, before the Texas House of Representatives.
I submitted pro bono amicus curiae briefs and oral argument in before appellate courts in New Jersey and California.
I submitted comments on "Development of Life-Sustaining Treatment Guidelines" to the Virginia Joint Commission on Health Care (November 2016).
Past Positions Concerning End-of-Life
I co-chaired the Minnesota POLST Task Force, a project housed by the Minnesota Medical Association.
I participated on a multidisciplinary task force bringing MOLST to Delaware, and helped draft the DHSS regulations.
I served on the Minnesota Medical Association POLST Task Force.
I served on the Litigation Advocacy Advisory Committee, Compassion & Choices.
I have consulted with lead counsel in appellate litigation concerning medical treatment issues.
I served on the Board of the Delaware End-of-Life Coalition.
I served on a regional long-term care ethics committee in New Jersey.
Past Positions Concerning Healthcare Policy
I was a member of MEDCAC, the Medicare Evidence Development & Coverage Advisory Committee (2013-2015). MEDCAC reviews and evaluates medical literature, technology assessments, and examines data and information on the effectiveness and appropriateness of medical items and services that are covered under Medicare, or that may be eligible for coverage under Medicare. MEDCAC judges the strength of the available evidence and makes recommendations to CMS based on that evidence.
I made frequent presentations to community and professional groups on health policy issues.
I served on a large hospital system's ethics committee (Christiana Care Health System).
I served on the institutional review board (IRB) of Widener University.